Regeneus

Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.

Contact Details

2 Paddington Street , PADDINGTON NSW 2021

02 9499 8010

info@regeneus.com.au

www.regeneus.com.au

Lists and Charts

Share price

Regeneus
Closing price for the last 90 trading days

View ASX Chart

Revenue

Rank		Company	#
1006^th	-	Regeneus	$1.06m

1330 public companies - non WA ranked by total revenue

View Full List

Company Share Transactions

Company Activity

	NEWS: Tagged in Regeneus trebles on back of merger deal	05 Apr 2024
	NEW ROLE: John Chiplin, Non-Executive Director	03 Nov 2020
	NEW ROLE: Graham Vesey, Chief Scientific Officer, Executive Director	03 Nov 2020
	NEW ROLE: Alan Dunton, Non-Executive Director	03 Nov 2020
	NEW ROLE: Leo Lee, Non-Executive Director	03 Nov 2020
	NEW ROLE: Sandra McIntosh, Company Secretary	03 Nov 2020
	NEW ROLE: Karolis Rosickas, Chief Executive Officer	03 Nov 2020
	NEW ROLE: Barry Sechos, Non-Executive Director, Chair since 2019	03 Nov 2020

Related Information

Access to our data for Regeneus is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Regeneus is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today